Joshua J Gagne
Biographic Data
| ID | 5534783 |
|---|---|
| NAME | Joshua J Gagne |
| GIVEN NAMES | Joshua J |
| FAMILY NAME | Gagne |
| SIGNATURE | GAGNE J J |
| AFFILIATIONS | Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School |
| ORCID | 0000-0001-5428-9733 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 8 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 1 |
Estimating Rebates and Other Discounts Received by Medicare Part D
Models that fail to properly account for increasing rebates and other discounts will overestimate Medicare Part D expenditures. Rigorous and transparent methods for estimating discounts are critical for understanding patterns in spending and developing new cost-containment strategies
Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10
OBJECTIVES: To validate and compare performance of an International Classification of Diseases, tenth revision (ICD-10) version of a combined comorbidity index merging conditions of Charlson and Elixhauser measures against individual measures in the prediction of 30-day mortality. To select a weight derivation method providing optimal performance across ICD-9 and ICD-10 coding systems. RESEARCH DESIGN: Using 2 adult population-based cohorts of pa…
The Potential Return on Public Investment in Detecting Adverse Drug Effects
BACKGROUND: Many countries lack fully functional pharmacovigilance programs, and public budgets allocated to pharmacovigilance in industrialized countries remain low due to resource constraints and competing priorities. OBJECTIVE: Using 3 case examples, we sought to estimate the public health and economic benefits resulting from public investment in active pharmacovigilance programs to detect adverse drug effects. RESEARCH DESIGN: We assessed 3 e…
Adaptation and Validation of the Combined Comorbidity Score for ICD-10-CM
BACKGROUND: The combined comorbidity score, which merges the Charlson and Elixhauser comorbidity indices, uses the ninth revision of the International Classification of Diseases, Clinical Modification (ICD-9-CM). In October 2015, the United States adopted the 10th revision (ICD-10-CM). OBJECTIVE: The objective of this study is to examine different coding algorithms for the ICD-10-CM combined comorbidity score and compare their performance to the …
Trust Yet Verify
Trust Yet Verify: Physicians as Trusted Sources of Health Information on HPV for Black Women in Socioeconomically Marginalized Populations Cheryl R. Clark, MD, ScD , Nashira C. Baril, MPH , Erline Achille, BA , Shauntell Foster, MBA , Natacha Johnson, BS , Kalahn Taylor-Clark, PhD, MPH , Joshua J. Gagne, MA , Oluwakemi Olukoya, MBBS, MPH , Carrie E. Huisingh, MPH , Mark J. Ommerborn, MPH , and K. Viswanath, PhD What Is the Purpose of This Study? …
Trust Yet Verify
Our study suggests that physicians are trusted and preferred sources of information on HPV for Black women of low SEP in Boston. Our data underscore an important avenue for intervention: to improve dissemination of HPV-related information through physicians, including outreach in community settings
Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Confounding Adjustment in Comparative Effectiveness Research Conducted Within Distributed Research Networks
BACKGROUND: A distributed research network (DRN) of electronic health care databases, in which data reside behind the firewall of each data partner, can support a wide range of comparative effectiveness research (CER) activities. An essential component of a fully functional DRN is the capability to perform robust statistical analyses to produce valid, actionable evidence without compromising patient privacy, data security, or proprietary interest…
Trust Yet Verify
Our study suggests that physicians are trusted and preferred sources of information on HPV for Black women of low SEP in Boston. Our data underscore an important avenue for intervention: to improve dissemination of HPV-related information through physicians, including outreach in community settings
Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Confounding Adjustment in Comparative Effectiveness Research Conducted Within Distributed Research Networks
BACKGROUND: A distributed research network (DRN) of electronic health care databases, in which data reside behind the firewall of each data partner, can support a wide range of comparative effectiveness research (CER) activities. An essential component of a fully functional DRN is the capability to perform robust statistical analyses to produce valid, actionable evidence without compromising patient privacy, data security, or proprietary interest…
Trust Yet Verify
Trust Yet Verify: Physicians as Trusted Sources of Health Information on HPV for Black Women in Socioeconomically Marginalized Populations Cheryl R. Clark, MD, ScD , Nashira C. Baril, MPH , Erline Achille, BA , Shauntell Foster, MBA , Natacha Johnson, BS , Kalahn Taylor-Clark, PhD, MPH , Joshua J. Gagne, MA , Oluwakemi Olukoya, MBBS, MPH , Carrie E. Huisingh, MPH , Mark J. Ommerborn, MPH , and K. Viswanath, PhD What Is the Purpose of This Study? …
Trust Yet Verify
Our study suggests that physicians are trusted and preferred sources of information on HPV for Black women of low SEP in Boston. Our data underscore an important avenue for intervention: to improve dissemination of HPV-related information through physicians, including outreach in community settings
The Potential Return on Public Investment in Detecting Adverse Drug Effects
BACKGROUND: Many countries lack fully functional pharmacovigilance programs, and public budgets allocated to pharmacovigilance in industrialized countries remain low due to resource constraints and competing priorities. OBJECTIVE: Using 3 case examples, we sought to estimate the public health and economic benefits resulting from public investment in active pharmacovigilance programs to detect adverse drug effects. RESEARCH DESIGN: We assessed 3 e…
Adaptation and Validation of the Combined Comorbidity Score for ICD-10-CM
BACKGROUND: The combined comorbidity score, which merges the Charlson and Elixhauser comorbidity indices, uses the ninth revision of the International Classification of Diseases, Clinical Modification (ICD-9-CM). In October 2015, the United States adopted the 10th revision (ICD-10-CM). OBJECTIVE: The objective of this study is to examine different coding algorithms for the ICD-10-CM combined comorbidity score and compare their performance to the …
Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10
OBJECTIVES: To validate and compare performance of an International Classification of Diseases, tenth revision (ICD-10) version of a combined comorbidity index merging conditions of Charlson and Elixhauser measures against individual measures in the prediction of 30-day mortality. To select a weight derivation method providing optimal performance across ICD-9 and ICD-10 coding systems. RESEARCH DESIGN: Using 2 adult population-based cohorts of pa…
Estimating Rebates and Other Discounts Received by Medicare Part D
Models that fail to properly account for increasing rebates and other discounts will overestimate Medicare Part D expenditures. Rigorous and transparent methods for estimating discounts are critical for understanding patterns in spending and developing new cost-containment strategies
Medicine (8 works) · Family medicine (4 works) · Gerontology (4 works) · Internal Medicine (4 works) · Cancer (3 works) · Chronic Disease Management Strategies (3 works) · Environmental health (3 works) · Mathematics (3 works) · Psychiatry (3 works) · Public health (3 works)